CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
Author
Cemiplimab approved for treatment of CSCC
Gandara DR
+9 more
Giuseppe Lo Russo
Jacob J. Adashek
Kurra V
Nivolumab approved for lung cancer
Razelle Kurzrock
Roberto Ferrara
Shumei Kato
Singavi AK
Zuazo‐Ibarra M
Publication venue
'Alphamed Press'
Publication date
Field of study
No full text
Crossref